C17H20N4O4.C2HF3O2
Neat
344.37 114.02
2093387-50-7; 4-((4-aminobutyl)amino)-2-(2, 6-dioxopiperidin-3-yl)isoindoline-1, 3-dione 2, 2, 2-trifluoroacetate; Thalidomide-NH-C4-NH2 TFA; Thalidomide-NH-C4-NH2 (TFA); Pomalidomide-C4-amine TFA; LCZC1079; orb1987630; SCHEMBL28576091; EX-A3954; AKOS040743970; DA-68116; HY-130814; CS-0114220; E83728; 4-(4-aminobutylamino)-2-(2, 6-dioxo-3-piperidyl)isoindoline-1, 3-dione;2, 2 and 2-trifluoroacetic acid
4-(4-aminobutylamino)-2-(2, 6-dioxopiperidin-3-yl)isoindole-1, 3-dione;2, 2 and 2-trifluoroacetic acid
InChI=1S/C17H20N4O4.C2HF3O2/c18-8-1-2-9-19-11-5-3-4-10-14(11)17(25)21(16(10)24)12-6-7-13(22)20-15(12)23;3-2(4,5)1(6)7/h3-5,12,19H,1-2,6-9,18H2,(H,20,22,23);(H,6,7)